LIPO (Lipella Pharmaceuticals) Book Value per Share: $0.32 (As of Sep. 2025)


What is Lipella Pharmaceuticals Book Value per Share?

Lipella Pharmaceuticals LIPO Book Value per Share is $0.32 as of Sep. 2025. The stock has 1 warning sign investors should review.

Lipella Pharmaceuticals's book value per share for the quarter that ended in Sep. 2025 was $0.32.

During the past 12 months, Lipella Pharmaceuticals's average Book Value Per Share Growth Rate was -75.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Lipella Pharmaceuticals was 86.00% per year. The lowest was -7.20% per year. And the median was 39.40% per year.

Lipella Pharmaceuticals's current price is $0.065. Its book value per share for the quarter that ended in Sep. 2025 was $0.32. Hence, today's PB Ratio of Lipella Pharmaceuticals is 0.20.

During the past 5 years, the highest P/B Ratio of Lipella Pharmaceuticals was 5.46. The lowest was 0.06. And the median was 1.90.


Lipella Pharmaceuticals  (OTCPK:LIPO) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Lipella Pharmaceuticals Book Value per Share Related Terms


Lipella Pharmaceuticals Book Value per Share Historical Data

* Premium members only.

The historical data trend for Lipella Pharmaceuticals's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipella Pharmaceuticals Book Value per Share Chart

Lipella Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Book Value per Share
0.65 1.98 6.51 4.15 1.59

Lipella Pharmaceuticals Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 1.59 1.60 0.61 0.32

LIPO vs IOBTQ, WINT, CYTOF: Book Value per Share Comparison

For the Biotechnology subindustry, Lipella Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipella Pharmaceuticals PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipella Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Lipella Pharmaceuticals's PB Ratio falls into.



Lipella Pharmaceuticals Book Value per Share Calculation

Lipella Pharmaceuticals's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.92-0.00)/1.21
=1.59

Lipella Pharmaceuticals's Book Value Per Share for the quarter that ended in Sep. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.49-0.00)/4.62
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of $0.32 mean?
Lipella Pharmaceuticals (LIPO) has a Book Value per Share of $0.32 as of Sep. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Lipella Pharmaceuticals and its competitors.
Is Lipella Pharmaceuticals' Book Value per Share too high?
Lipella Pharmaceuticals' current Book Value per Share is $0.32.
How does Lipella Pharmaceuticals' Book Value per Share compare to IOBTQ and WINT?
Lipella Pharmaceuticals' Book Value per Share of $0.32 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Lipella Pharmaceuticals and its competitors. Lipella Pharmaceuticals's current Book Value per Share is $0.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lipella Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lipella Pharmaceuticals (LIPO) is currently considered Possible Value Trap. The stock's GF Value™ is $8.70, compared to a current price of $0.07 — trading 99.3% below its estimated fair value. The current Book Value per Share is $0.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Lipella Pharmaceuticals (LIPO), the current Book Value per Share is $0.32 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lipella Pharmaceuticals Business Description

Address 7800 Susquehanna Street, Suite 505, Pittsburgh, PA, USA, 15208
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.